CPI Corp. (NYSE:CPY) reported results for the fiscal 2011 first quarter ended April 30, 2011. Fiscal 2011 first-quarter sales declined 7% to $88.6 million from $95.5 million in the prior-year first quarter. First-quarter Picture Me Portrait Studio® brand comparable store sales, described herein, decreased 9% versus the same period last year. First-quarter Sears Portrait Studio brand comparable store sales, described herein, decreased 16% versus the same period last year.
CPI Corp., through its subsidiaries, manufactures and sells professional portrait photography of young children, individuals, and families. It offers portrait photography of babies, preschoolers, school-age children, adults, families/groups, weddings, passports, and churches, as well as cruise ships, conventions/events, glamour, and business portraits.
Power3 Medical Products, Inc (PWRM)
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
Alzheimer's disease is a neurodegenerative disorder prevalent in the senile population. It is clinically characterized by the progressive loss of memory and other cognitive abilities and pathologically by severe neuronal loss, glial proliferation and amyloid plaques composed of ?-amyloid protein (A?) surrounded by degenerated nervous terminations and neurofibrilar tangles. This pathology is diagnosed when other dementia causes are excluded, because only necropsy permits the establishment of a definitive AD diagnosis.
The NuroPro Blood Test is Power3 Medical's diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system.
The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms. The NuroPro Test is currently in the development stages.
Power3 Medical has completed proof-of-concept and clinical validation studies, with results exceeding expectations. Currently, Power3 Medical has commenced a three hundred patient clinical validation study of its NuroPro diagnostic test for Alzheimer's disease and Parkinson's disease.
Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Please visit Power3 Medical Products, Inc website http://www.power3medical.com.
Crown Equity Holdings Inc., (CRWE)
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers.
Online marketing can be done using different online tools that aid in marketing products. Lot of information about products and services can be shared using the internet. A good way to market products will be to place ads on blogs, videos, web applications etc.
Crown Equity Holdings Inc. announced that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.
Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
For more information, visit http://www.crownequityholdings.com
Campus Crest Communities, Inc (NYSE:CCG) announced that its Board declared its second quarter 2011 dividend of $0.16 per common share and operating partnership unit. The dividend is payable on July 13, 2011, to shareholders of record on June 29, 2011.
Campus Crest Communities, Inc. focuses on building, owning, and managing student housing properties in the United States. It leases student housing; offers student housing services; and provides development, construction, and management services. The company was founded in 2004 and is based in Charlotte, North Carolina.
Artio Global Investors Inc. (NYSE:ART) reported preliminary month-end assets under management of $49.2 billion as of May 31, 2011, compared to $51.8 billion as of April 30, 2011.
Artio Global Investors, Inc. is a publicly owned asset management holding company. Through its subsidiary, the firm provides portfolio management and fund management services to its clients. Artio Global Investors, Inc. was founded in 1962 and is based in New York, New York.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).